(Adds details, comment)
ZURICH, April 2 (Reuters) - Swiss contract drug
manufacturer Lonza LONN.S on Tuesday named Wolfgang Wienand,
CEO of Siegfried Holding SFZN.S , as its new chief executive.
Wienand, who has led the Swiss contract development and
manufacturing (CDMO) company since 2019, will replace Chairman
Albert Baehny, who has served as interim CEO at Lonza since
October 2023.
Wienand will join Basel-based Lonza in the summer of 2024,
the company said, while Baehny will retire following a
transition period.
Before becoming CEO at Siegfried, Wienand was chief
scientific officer and chief strategy officer at the company,
which produces pharmaceutical ingredients and finished products.
"The board is delighted to have appointed a seasoned CEO
with a strong and established track record of success in the
CDMO industry," Baehny said in a statement.
"Wolfgang brings a wealth of knowledge and experience to
Lonza, complemented by his deep scientific and strategic
expertise," he added.
(Reporting by John Revill, Editing by Rachel More)
((John.Revill@thomsonreuters.com; +41 41 528 36 37; Reuters
Messaging: john.revill.thomsonreuters.com@reuters.net))